Curis Announces Private Placement Closing with $80.8 Million in Gross Proceeds
ByAinvest
Friday, Jan 9, 2026 8:07 am ET1min read
CRIS--
Curis, a biotech company, has closed a private placement for $20.2 million, part of a total of $80.8 million. The financing was led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, and The Red Hook Fund. Other institutional investors, management team members, and board directors also participated. Laidlaw & Company acted as sole placement agent. The funds will support the development of emavusertib, an IRAK4 and FLT3 inhibitor.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet